fr 41565 has been researched along with Burkitt Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, S; Sodhi, A | 1 |
| Basu, S; Singh, SM; Sodhi, A; Suresh, A | 1 |
2 other study(ies) available for fr 41565 and Burkitt Lymphoma
| Article | Year |
|---|---|
Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.
Topics: Antibiotics, Antineoplastic; Burkitt Lymphoma; Cell Communication; Cisplatin; Drug Interactions; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocytes, Mononuclear; Microscopy, Electron; Oligopeptides; Tumor Cells, Cultured | 1992 |
Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin.
Topics: Antibiotics, Antineoplastic; Burkitt Lymphoma; Cisplatin; Cytotoxicity, Immunologic; Drug Synergism; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Kinetics; Lymphocyte Activation; Oligopeptides; Tumor Cells, Cultured; Up-Regulation | 1991 |